Genmab Share Price Nasdaq Copenhagen
Stocks
DK0010272202
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,818.25 DKK | +49.40% |
|
+4.14% | +14.24% |
| 10:25am | Nordic stocks in North America, AstraZeneca rose 1.3% | FW |
| 01/07 | Healthcare Stocks Fall as Markets Rotate Back to Tech -- Healthcare Roundup | DJ |
| Market Cap | 11TCr 1.68TCr 1.47TCr 1.36TCr 1.27TCr 2.39TCr 1,59200Cr 2.43TCr 16TCr 6.34TCr 79TCr 6.33TCr 6.19TCr 2,73700Cr | P/E 2026 * |
23.5x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 13TCr 1.98TCr 1.74TCr 1.6TCr 1.49TCr 2.82TCr 1,87400Cr 2.87TCr 19TCr 7.46TCr 92TCr 7.45TCr 7.28TCr 3,22200Cr | EV / Sales 2026 * |
4.68x | EV / Sales 2027 * | 3.78x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab
| 1 day | -0.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +49.40% | +4.14% | - | - | 1.68TCr | |
| +0.35% | +8.76% | +71.23% | +133.03% | 5.76TCr | |
| -1.32% | +17.12% | +79.02% | +99.82% | 5.51TCr | |
| -1.28% | +2.68% | -12.60% | -13.79% | 2.35TCr | |
| +1.79% | +4.38% | +5.94% | +405.31% | 2.31TCr | |
| -1.93% | +11.11% | +34.89% | -7.86% | 1.81TCr | |
| +0.24% | +5.98% | +23.45% | +184.72% | 1.37TCr | |
| +0.14% | +9.60% | +33.31% | - | 1.3TCr | |
| +1.83% | +4.58% | +77.42% | +132.45% | 1.24TCr | |
| -2.37% | +6.47% | +157.84% | +161.16% | 1.16TCr | |
| Average | -0.29% | +5.83% | +52.28% | +136.86% | 2.54TCr | |
| Weighted average by Cap. | -0.33% | +4.94% | +54.67% | +130.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.77TCr 423.68Cr 370.85Cr 342.34Cr 319.33Cr 601.67Cr 40TCr 612.44Cr 4.11TCr 1.59TCr 20TCr 1.59TCr 1.56TCr 69TCr | 3.25TCr 495.92Cr 434.08Cr 400.71Cr 373.78Cr 704.26Cr 47TCr 716.86Cr 4.81TCr 1.87TCr 23TCr 1.86TCr 1.82TCr 81TCr |
| Net income | 476.18Cr 73Cr 64Cr 59Cr 55Cr 103.33Cr 6.88TCr 105.18Cr 705.25Cr 273.8Cr 3.4TCr 273.38Cr 267.28Cr 12TCr | 702.99Cr 107.42Cr 94Cr 87Cr 81Cr 152.55Cr 10TCr 155.28Cr 1.04TCr 404.21Cr 5.01TCr 403.59Cr 394.58Cr 17TCr |
| Net Debt | 1.95TCr 298.32Cr 261.12Cr 241.04Cr 224.84Cr 423.64Cr 28TCr 431.22Cr 2.89TCr 1.12TCr 14TCr 1.12TCr 1.1TCr 48TCr | 1.25TCr 190.81Cr 167.01Cr 154.17Cr 143.81Cr 270.97Cr 18TCr 275.81Cr 1.85TCr 717.95Cr 8.9TCr 716.87Cr 700.86Cr 31TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
